From The Cover: Evolutionarily divergent herpesviruses modulate T cell activation by targeting the herpesvirus entry mediator cosignaling pathway-Reference-Cited by-同舟云学术

From The Cover: Evolutionarily divergent herpesviruses modulate T cell activation by targeting the herpesvirus entry mediator cosignaling pathway

Published:2005-08-30 Issue:37 Volume:102 Page:13218-13223
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Cheung T. C.,Humphreys I. R.,Potter K. G.,Norris P. S.,Shumway H. M.,Tran B. R.,Patterson G.,Jean-Jacques R.,Yoon M.,Spear P. G.,Murphy K. M.,Lurain N. S.,Benedict C. A.,Ware C. F.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference37 articles.

1. CTLA-4: new insights into its biological function and use in tumor immunotherapy

2. The B7–CD28 superfamily

3. Negative co-receptors on lymphocytes

4. BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1

5. An Inhibitory Ig Superfamily Protein Expressed by Lymphocytes and APCs Is Also an Early Marker of Thymocyte Positive Selection

Cited by 181 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multilayered Computational Framework for Designing Peptide Inhibitors of HVEM-LIGHT Interaction;The Journal of Physical Chemistry B;2024-07-03

2. Soluble immune checkpoints: implications for cancer prognosis and response to immune checkpoint therapy and conventional therapies;Journal of Experimental & Clinical Cancer Research;2024-05-31

3. The effect of gD-derived peptides on T cell immune response mediated by BTLA-HVEM protein complex in melanoma patients;Frontiers in Immunology;2024-05-21

4. The role of the BTLA–HVEM complex in the pathogenesis of breast cancer;Breast Cancer;2024-03-14

5. The BTLA-HVEM complex – The future of cancer immunotherapy;European Journal of Medicinal Chemistry;2024-03